MX2009003929A - Composiciones de fenilalquil carbamato. - Google Patents

Composiciones de fenilalquil carbamato.

Info

Publication number
MX2009003929A
MX2009003929A MX2009003929A MX2009003929A MX2009003929A MX 2009003929 A MX2009003929 A MX 2009003929A MX 2009003929 A MX2009003929 A MX 2009003929A MX 2009003929 A MX2009003929 A MX 2009003929A MX 2009003929 A MX2009003929 A MX 2009003929A
Authority
MX
Mexico
Prior art keywords
phenylalkyl carbamate
phenylalkyl
carbamate compositions
carbamate compound
compositions
Prior art date
Application number
MX2009003929A
Other languages
English (en)
Inventor
James Mccool
Ramendra N Pandey
Tracey Mascaro
Ronnie Mcdowell
John Troisi
Stanley Altan
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39111848&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009003929(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2009003929A publication Critical patent/MX2009003929A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a una composición de un compuesto de fenilalquil carbamato que da como resultado una estabilidad mejorada, en donde la composición comprende un compuesto de fenilalquil carbamato en mezcla con una cantidad efectiva de uno o más excipientes y, en donde al menos un excipiente es un fosfato de calcio dibásico dihidratado.
MX2009003929A 2006-10-13 2007-10-08 Composiciones de fenilalquil carbamato. MX2009003929A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82935506P 2006-10-13 2006-10-13
PCT/US2007/080677 WO2008048802A1 (en) 2006-10-13 2007-10-08 Phenylalkyl carbamate compositions

Publications (1)

Publication Number Publication Date
MX2009003929A true MX2009003929A (es) 2009-06-26

Family

ID=39111848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003929A MX2009003929A (es) 2006-10-13 2007-10-08 Composiciones de fenilalquil carbamato.

Country Status (23)

Country Link
US (1) US20080090903A1 (es)
EP (1) EP2089002A1 (es)
JP (1) JP2010506846A (es)
KR (1) KR20090067210A (es)
CN (1) CN101663026A (es)
AR (1) AR063294A1 (es)
AU (1) AU2007313018A1 (es)
BR (1) BRPI0719236A2 (es)
CA (1) CA2673526A1 (es)
CL (1) CL2007002943A1 (es)
CO (1) CO6190539A2 (es)
CR (1) CR10793A (es)
EA (1) EA200970378A1 (es)
IL (1) IL198144A0 (es)
MX (1) MX2009003929A (es)
NI (1) NI200900055A (es)
NO (1) NO20091492L (es)
PE (1) PE20080887A1 (es)
SV (1) SV2009003222A (es)
TW (1) TW200831134A (es)
UY (1) UY30643A1 (es)
WO (1) WO2008048802A1 (es)
ZA (1) ZA200903284B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263652B2 (en) * 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
CA2803825C (en) * 2010-07-02 2015-12-29 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CA2859129C (en) 2011-12-27 2020-07-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy
WO2014097137A2 (en) * 2012-12-18 2014-06-26 Mahesh Kandula Compositions and methods for the treatment of seizures and neurologic diseases
WO2014142477A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
JP6126251B2 (ja) 2013-03-12 2017-05-10 バイオ−ファーム ソリューションズ カンパニー リミテッド フェニルカルバメート化合物及びこれを含む神経ガスによる疾患の予防又は治療用組成物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄａｎｄａｃｏｍｐｏｓｉｔｉｏｎｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇａｎｅｒｖｅｇａｓ−ｉｎｄｕｃｅｄｄｉｓｅａｓｅｃｏｍｐｒｉｓｉｎｇｔｈｅｓａｍｅ｝
CN109071424B (zh) * 2016-02-29 2022-01-14 生物药品解决方案有限公司 氨基磺酸酯衍生物化合物、其制备方法及用途
BR112018067674B1 (pt) * 2016-02-29 2023-01-10 Bio-Pharm Solutions Co., Ltd. Compostos derivados de carbamato, composição farmacêutica e seus usos para tratamento ou prevenção de distúrbios do snc e/ou dor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US20020147229A1 (en) * 2000-08-17 2002-10-10 Allerton Charlotte Moira Norfor Pharmaceuticals
WO2003030920A1 (en) * 2001-10-08 2003-04-17 Sun Pharmaceutical Industries Limited An antispasmodic agent spaced drug delivery system

Also Published As

Publication number Publication date
JP2010506846A (ja) 2010-03-04
IL198144A0 (en) 2009-12-24
CR10793A (es) 2009-09-29
EA200970378A1 (ru) 2009-10-30
CA2673526A1 (en) 2008-04-24
TW200831134A (en) 2008-08-01
AU2007313018A1 (en) 2008-04-24
CO6190539A2 (es) 2010-08-19
CL2007002943A1 (es) 2008-04-18
PE20080887A1 (es) 2008-06-28
CN101663026A (zh) 2010-03-03
NO20091492L (no) 2009-07-09
EP2089002A1 (en) 2009-08-19
KR20090067210A (ko) 2009-06-24
UY30643A1 (es) 2008-05-02
US20080090903A1 (en) 2008-04-17
BRPI0719236A2 (pt) 2014-07-08
WO2008048802A1 (en) 2008-04-24
AR063294A1 (es) 2009-01-21
SV2009003222A (es) 2009-10-15
ZA200903284B (en) 2010-07-28
NI200900055A (es) 2010-02-01

Similar Documents

Publication Publication Date Title
MX2009003926A (es) Composiciones de fenilalquilamino-carbamato.
MX2009003929A (es) Composiciones de fenilalquil carbamato.
ZA200903305B (en) Concentrated Surfactant Compositions
EP2086540B8 (en) Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
BRPI0514766A (pt) composições farmacêuticas
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
IL195341A (en) A method of preparing simvastatin and compounds containing simvastatin
MX2009013047A (es) Composiciones adecuadas para uso como compuestos para juntas y metodos relacionados.
UA92894C2 (ru) Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата
PL1833465T3 (pl) Liofilizacja wirosomów
SG10201407504YA (en) Pharmaceutical compositions comprising sigma receptor ligands
GEP20146063B (en) Solid pharmaceutical composition
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
ZA201003380B (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
EA200602187A1 (ru) Фармацевтическая композиция и способ её получения
TW200800993A (en) Organic compounds
EA200401218A1 (ru) Фармацевтическая композиция, содержащая фозиноприл
BR112015010119A2 (pt) composição farmacêutica que contém um inibidor de ace e um bloqueador do canal de cálcio
TW200734325A (en) Compounds
TR200904341A2 (tr) Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
UA48127U (en) Fungicidal composition
GEP20125604B (en) Novel compounds of 2-mercapto-cyclopentanecarboxyl acid, preparation method and pharmaceutical compositions thereof